Stock listing

ASX:IME ImExHS Ltd Share Price

Follow ImExHS Ltd into a list and get an email when it puts out news.

Share price · ASX:IME

$0.31 AUD 0.00 (0.0%)

Close on Nov 19, 2026

Past year +10.7% · daily closes, Nov 21, 2025 – Nov 19, 2026, adjusted for splits
Day range
$0.31 – $0.31 AUDNov 19, 2026
Volume
2,900 sharesNov 19, 2026
Market cap
$16.86M AUDAt the close on Nov 19, 2026 · price × 54.40M shares outstanding
52-week range
$0.27 – $0.47 AUDLowest and highest trades, Nov 21, 2025 – Nov 19, 2026
Traded on an average day
$5,175 AUDMedian day 9,028 shares · last 3 months, Aug 24, 2026 – Nov 19, 2026
ImExHS Ltd logo

Daily closes

Last 3 months, Aug 24, 2026 – Nov 19, 2026 · ASX:IME · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.310.000.0%$0.31$0.31$0.312,900
$0.31-0.02-6.1%$0.31$0.31$0.312,500
$0.330.000.0%$0.32$0.33$0.321,535
$0.330.000.0%$0.33$0.33$0.334,382
$0.33-0.015-4.3%$0.33$0.33$0.331,579
$0.3450.000.0%$0.345$0.345$0.34511,480
$0.3450.000.0%$0.345$0.345$0.345216
$0.3450.000.0%$0.33$0.345$0.335,064
$0.345+0.005+1.5%$0.33$0.345$0.335,064
$0.34-0.005-1.4%$0.34$0.34$0.3410,000
$0.3450.000.0%$0.33$0.345$0.339,272
$0.345+0.015+4.5%$0.33$0.345$0.339,272
$0.33+0.01+3.1%$0.325$0.33$0.3232,136
$0.320.000.0%$0.32$0.32$0.3210,000
$0.32+0.015+4.9%$0.32$0.32$0.3210,000
$0.305-0.025-7.6%$0.34$0.34$0.30514,620
$0.33+0.03+10.0%$0.31$0.33$0.31210,694
$0.300.000.0%$0.305$0.305$0.3040,000
$0.30-0.025-7.7%$0.30$0.30$0.3037,515
$0.3250.000.0%$0.325$0.325$0.3254,492
$0.325+0.01+3.2%$0.32$0.325$0.3223,000
$0.315+0.015+5.0%$0.315$0.315$0.3153,311
$0.30+0.02+7.1%$0.30$0.30$0.30136
$0.28-0.02-6.7%$0.30$0.30$0.287,173
$0.30-0.025-7.7%$0.30$0.30$0.2923,627
$0.3250.000.0%$0.305$0.325$0.2820,000
$0.325+0.005+1.6%$0.325$0.325$0.32510,000
$0.320.000.0%$0.33$0.33$0.3220,782
$0.32-0.035-9.9%$0.355$0.355$0.323,500
$0.3550.000.0%$0.355$0.355$0.355162
$0.355+0.005+1.4%$0.35$0.355$0.3515,000
$0.350.000.0%$0.35$0.35$0.354,838
$0.350.000.0%$0.35$0.35$0.358,784
$0.350.000.0%$0.35$0.35$0.34516,928
$0.35+0.04+12.9%$0.31$0.35$0.3111,999
$0.310.000.0%$0.31$0.31$0.311,629
$0.310.000.0%$0.31$0.31$0.3057,203
$0.310.000.0%$0.305$0.31$0.3054,171

Splits

5 splits since 2007 · ASX:IME · every price before a split is adjusted for it

DayRatioWhat
1-for-50Consolidation
1-for-10Consolidation
1-for-3Consolidation
1-for-10Consolidation
20-for-11Split
Ticker
ASX:IME
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
ASX
Currency
AUD

What changed lately

Latest news

H1 FY26 Results Presentation

Sep 1, 2026

Closed $0.355 (+1.4%) on Sep 2, 2026

IMEXHS Reports 1H FY26 Results

Aug 27, 2026

Closed $0.35 (0.0%) on Aug 28, 2026

Notice of 1H FY26 Results Presentation

Aug 27, 2026

Closed $0.35 (0.0%) on Aug 28, 2026

Half Yearly Report and Accounts

Aug 27, 2026

Closed $0.35 (0.0%) on Aug 28, 2026

Change in Registered Office

Jul 27, 2026

Closed $0.28 (-8.2%) on Jul 28, 2026

IMEXHS Wins Aquila Public Tender in Mexico

May 24, 2026

Closed $0.37 (+2.8%) on May 25, 2026

All ImExHS Ltd news

ImExHS Ltd on 6ix

Sector
Health care
Industry
Health care services
News releases
17 in the last 12 months · 140 in all · newest Oct 27, 2026 · oldest 2016
Decks
40 decks · latest Sep 2, 2026

Valuation

EV/sales 0.5× against a median of 1.2×: 3rd lowest of 10 Health care services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 19, 2026

Enterprise value
$15.33M AUD
P/E
Loss
EV/sales
0.5×
EV/EBITDA
10.1×
Price/book
1.0×
Gross margin
28.7%
Operating margin
−2.4%
Net margin
−10.0%
Debt to equity
0.0×
Beta
No index for this market yet

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
ImExHS Ltd · ASX:IMEUS$11.16MUS$10.15Mn/a0.5×10.1×1.0×−10.0%0.0×n/a
Mukdahan International Hospital Public Company Limited · SET:HANNUS$12.20MUS$9.07M66.8×0.7×6.3×1.4×1.4%0.1×n/a
Alzai Health Corp. · TSXV:ALZIUS$11.86MUS$10.93Mn/a227×n/a11.2×n/a0.4×n/a
Unipharma Co., Ltd. · TPEX:6621US$11.79MUS$8.53Mn/a3.2×n/a2.0×−45.8%0.0×n/a
Eukedos SpA · MIL:EUKUS$11.73MUS$11.27Mn/a0.2×1.2×0.4×−1.4%0.0×n/a
Intrasense SA · EURONEXT:ALINSUS$11.00MUS$10.61Mn/a3.3×n/an/a−364.8%n/an/a
iTonic Holdings Ltd · NASDAQ:ITOCUS$10.87MUS$8.90Mn/a17.0×n/a0.5×−974.7%0.0×1.06
Republic Healthcare Limited · HKEX:8357US$10.83MUS$9.29Mn/a1.2×n/a1.8×−40.3%0.4×n/a
Scandinavian Medical Solutions A/S · OMXCOP:SMSMEDUS$10.61MUS$21.25M2,780×0.6×13.9×1.0×0.0%1.0×n/a
Medilines Distributors, Inc. · PSE:MEDICUS$10.33MUS$9.37Mn/an/an/a0.3×n/a0.0×n/a
KT Medical Service Public Company Limited · SET:KTMSUS$10.25MUS$8.24M9.6×0.4×2.8×0.6×5.1%0.0×n/a
Median of the othersUS$10.94MUS$9.33M66.8×1.2×4.6×1.0×−20.9%0.0×1.06

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
0.37 AUD · Analysts' mean
EPS, year to Dec 2026
-0.000 · 1 analyst
Revenue, year to Dec 2026
32.85M · 1 analyst

Team and board

Officers

OfficerRole
Germán ArangoCEO & Co-Founder
Reena MinhasChief Financial Officer
Jorge MarínChief Medical Officer & Co-Founder
Orlando JóvenChief Operations Officer

Board

DirectorRole
Doug FlynnNon-Executive Chairman
Carlos PalacioNon-Executive Director
Damian BanksNon-Executive Director
Doug LingardNon-Executive Director

Events

QuarterResultsShare move
Quarter to Sep 30, 2025Nov 3, 2025+3.7%
Q2 2025Aug 28, 2025 · Before open−2.2%
Quarter to Mar 31, 2025Apr 30, 20250.0%
Q4 2024Mar 30, 20250.0%
Quarter to Sep 30, 2024Nov 27, 2024−5.6%
Q2 2024Aug 29, 20240.0%
Quarter to Mar 31, 2024May 29, 20240.0%
Q4 2023Feb 28, 2024−4.6%
Quarter to Sep 30, 2023Oct 30, 2023 · Before open−1.4%
Q2 2023Aug 31, 2023 · After close
All 19 quarters
QuarterResultsShare move
Q1 2023Apr 28, 2023 · After close−3.7%
Q4 2022Feb 28, 2023 · Before open0.0%
Q3 2022Oct 31, 2022 · Before open0.0%
Q2 2022Aug 30, 2022 · Before open+7.9%
Q1 2022May 18, 2022−1.4%
Q4 2021Feb 28, 2022 · Before open0.0%
Q3 2021Dec 1, 2021+6.3%
Q2 2021Aug 30, 2021−11.0%
Q4 2020Feb 25, 2021−3.4%

Open Events

Decks

DeckKindSlidesDate
H1 FY26 Earnings PresentationEarnings30 slidesSep 2, 2026
Shareholder Meeting (May 2026)Shareholder meeting51 slidesMay 20, 2026
Investor Presentation (February 2026)Investor deck25 slidesFeb 27, 2026
Q3 FY25 Earnings PresentationEarnings20 slidesNov 4, 2025
H1 2025 Earnings PresentationEarnings28 slidesSep 2, 2025
Shareholder Meeting (May 2025)Shareholder meeting41 slidesMay 19, 2025
FY2024 Earnings PresentationEarnings38 slidesApr 3, 2025
FY2024 Earnings PresentationEarnings25 slidesFeb 28, 2025
H1 FY2024 Earnings PresentationEarnings24 slidesAug 30, 2024
Shareholder Meeting (April 2024)Shareholder meeting44 slidesApr 23, 2024
All 40 decks
DeckKindSlidesDate
Investor Presentation (February 2024)Investor deck24 slidesFeb 29, 2024
Q4 2023 Earnings PresentationEarnings13 slidesJan 30, 2024
Shareholder Meeting (September 2023)Shareholder meeting10 slidesSep 15, 2023
H1 FY2023 Earnings PresentationEarnings22 slidesAug 31, 2023
Shareholder Meeting (May 2023)Shareholder meeting37 slidesMay 16, 2023
Non-Deal Roadshow (March 2023)Roadshow27 slidesMar 23, 2023
Investor Presentation (February 2023)Investor deck25 slidesFeb 28, 2023
H1 2022 Earnings PresentationEarnings30 slidesAug 30, 2022
Investor Presentation (August 2022)Investor deck35 slidesAug 3, 2022
Shareholder Meeting (May 2022)Shareholder meeting32 slidesMay 19, 2022
Non-Deal Roadshow (March 2022)Roadshow17 slidesMar 21, 2022
Investor Presentation (February 2022)Investor deck31 slidesFeb 28, 2022
Morgans Technology Conference 2021Conference21 slidesNov 24, 2021
Shareholder Meeting (September 2021)Shareholder meeting22 slidesSep 29, 2021
H1 2021 Earnings PresentationEarnings31 slidesAug 30, 2021
Investor Presentation (July 2021)Investor deck16 slidesJul 26, 2021
Shareholder Meeting (May 2021)Shareholder meeting34 slidesMay 13, 2021
Coffee MicroCaps (March 2021)Conference19 slidesMar 18, 2021
FY2020 Earnings PresentationEarnings33 slidesFeb 26, 2021
Investor Presentation (October 2020)Investor deck25 slidesOctober 2020
H1 2020 Earnings PresentationEarnings38 slidesAug 31, 2020
Shareholder Meeting (May 2020)Shareholder meeting27 slidesMay 21, 2020
Investor Presentation (April 2020)Investor deck24 slidesApr 1, 2020
Microcap Conference (October 2019)Conference23 slidesOct 23, 2019
Investor Presentation (May 2019)Investor deck26 slidesMay 21, 2019
Investor Presentation (May 2019)Investor deck11 slidesMay 6, 2019
Investor Presentation (March 2019)Investor deck20 slidesMar 5, 2019
Investor Presentation (November 2018)Investor deck22 slidesNov 15, 2018
Corporate Update (September 2018)Corporate update24 slidesSep 10, 2018
Investor Presentation (May 2018)Investor deck21 slidesMay 17, 2018

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue29.0M26.6M19.7M17.1M13.4M10.9M7.74M5.78M3.55M80.1K
Cost of revenue20.7M15.5M16.2M13.6M8.20M6.46M5.04M3.40M2.90M1.77M
Gross profit8.31M11.0M3.50M3.52M5.22M2.70M2.70M2.38M648.8K-1.69M
Research and development2.26M2.92M2.44M1.53M1.11M646.7K2.12M1.34M19.5K280.7K
Selling, general and administrative8.29M7.46M5.54M5.61M6.09M4.42M3.78M2.79M243.6K2.41M
Operating income-697.6K-367.1K-2.70M-2.42M-3.14M-2.31M-5.22M-1.17M-592.0K-3.98M
Depreciation and amortization2.22M2.15M2.43M1.76M1.24M1.02M825.9K306.7K244.2K20.8K
EBITDA1.52M1.78M-268.7K-664.7K-1.91M-1.28M-4.40M-862.3K-347.8K-3.96M
Interest expense375.0K468.9K332.1K442.7K311.1K1.21M899.5K528.1K00
Income before tax-3.04M-2.57M-4.28M-2.95M-4.56M-3.53M-6.04M-4.79M68.5K-4.49M
Income tax-156.6K57.6K172.7K92.4K143.4K87.9K-40.3K91.8K-661.0K1.01M
Net income-2.88M-2.63M-4.19M-3.04M-4.70M-3.62M-6.00M-4.89M68.5K-4.49M
Earnings per share, basic-0.06-0.06-0.10-0.09-0.15-0.15-0.31-0.370.01-98.56

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents3.30M2.07M2.36M1.91M4.19M10.8M7.15M2.45M964.0K187.7K
Short-term investments274.8K
Receivables7.73M5.89M5.33M6.22M6.15M4.03M2.69M3.36M574.7K156.6K
Inventory146.2K328.0K112.0K96.8K84.4K389.7K107.4K811.3K297.2K479.1K
Current assets13.4M9.26M8.92M8.51M10.7M15.2M10.9M7.14M1.54M348.4K
Property, plant and equipment3.12M3.30M4.65M3.73M4.50M3.45M3.42M1.59M446.5K499.7K
Goodwill3.35M4.61M4.80M4.86M5.42M
Total assets23.7M21.8M22.7M21.0M25.0M20.8M14.8M9.26M1.55M496.1K
Accounts payable3.55M3.12M2.45M2.03M2.44M1.46M870.2K1.90M74.1K539.2K
Current liabilities7.76M6.89M6.37M4.48M6.35M4.46M3.65M3.32M89.1K822.2K
Long-term debt13.9K365.3K215.7K542.8K1.29M728.0K826.9K0250.0K
Total debt566.3K1.19M1.29M1.12M2.40M1.70M2.10M188.5K457.4K250.0K
Total liabilities7.86M7.33M6.67M5.09M8.36M5.27M4.48M3.41M89.1K822.2K
Shareholders' equity15.9M14.5M16.0M15.9M16.7M15.5M10.3M5.85M1.46M-326.1K
Shares outstanding51.2M45.0M41.7M35.6M31.1M24.9M19.5M13.2M10.5M45.6K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations564.7K-634.7K2.61M-2.20M-2.97M-1.47M-4.09M-1.54M-109.9K-3.65M
Capital spending-320.5K-1.06M-2.20M-2.03M-2.56M-2.19M-2.30M-1.32M-370.5K-29.7K
Free cash flow244.2K-1.69M414.6K-4.23M-5.53M-3.65M-6.39M-2.86M-480.3K-3.68M
Cash from investing-1.19M-765.9K-2.13M-2.22M-3.39M-2.19M-2.46M-1.32M-696.4K-29.7K
Cash from financing1.68M1.18M-98.6K2.25M-161.8K7.40M11.3M5.26M1.47M244.4K
Dividends paid-1.97M-101.9K-6.93M-2.38M
Share buybacks-206.4K-122.8K-12.8K-362.8K-25.6K-575.5K-675.8K5.50M-84.0K-7.60K
Change in cash1.23M-289.8K449.9K-2.27M-6.61M3.65M4.70M2.44M776.2K-3.44M

Open Financials

Filings

FilingDateTypeFiled with
Quarterly Activities/Appendix 4C Cash Flow ReportOct 27, 2026Quarterly reportASX
H1 FY26 Results PresentationSep 1, 2026Other filingsASX
Notification of cessation of securities - IMESep 1, 2026Notification letterASX
IMEXHS Reports 1H FY26 ResultsAug 27, 2026ResultsASX
Notice of 1H FY26 Results PresentationAug 27, 2026ResultsASX
Half Yearly Report and AccountsAug 27, 2026Interim reportASX
Quarterly Activities/Appendix 4C Cash Flow ReportJul 30, 2026Quarterly reportASX
Change in Registered OfficeJul 27, 2026Other filingsASX
Resignation and Appointment of Company SecretaryJul 27, 2026Management or board changeASX
IMEXHS Wins Aquila Public Tender in MexicoMay 24, 2026Operations updateASX
All 140 filings
FilingDateTypeFiled with
AGM - Chairman and CEO Addresses and PresentationMay 19, 2026Meeting noticeASX
FY26 Q1 Quarterly Activities Report and Appendix 4CApr 30, 2026Quarterly reportASX
IMEXHS launches agentic AI platform for radiologyApr 28, 2026Other filingsASX
IMEXHS FY25 Investor PresentationFeb 27, 2026Other filingsASX
IMEXHS Reports FY25 ResultsFeb 27, 2026ResultsASX
Appendix 4E & Annual Report 2025Feb 27, 2026Annual reportASX
2025 Q4 Quarterly Activities Report & Appendix 4CJan 29, 2026Quarterly reportASX
2025 Q3 Quarterly Activities Report & Appendix 4COct 30, 2025Quarterly reportASX
IMEXHS signs new radiology services contractSep 25, 2025Material contractASX
1H FY25 Results Investor PresentationSep 2, 2025ResultsASX
IMEXHS reports 1H F25 ResultsAug 29, 2025ResultsASX
Half Yearly Report and AccountsAug 29, 2025Interim reportASX
2025 Q2 Quarterly Activities Report and Appendix 4CJul 31, 2025Quarterly reportASX
Completion of Conditional PlacementMay 22, 2025FinancingASX
AGM - Chairman & CEO Addresses and PresentationMay 19, 2025Meeting outcomeASX
2025 Q1 Quarterly Activities Report & Appendix 4CApr 30, 2025Quarterly reportASX
IME FY24 Results & Capital Raising PresentationApr 2, 2025FinancingASX
IME Successfully Raises $2.5m to Support GrowthApr 2, 2025FinancingASX
Trading haltApr 1, 2025Trading halt or suspensionASX
Investor Presentation - FY24 Results (unaudited)Feb 27, 2025Other filingsASX
IMEXHS Reports FY24 Results (unaudited)Feb 27, 2025ResultsASX
Preliminary Final ReportFeb 27, 2025ResultsASX
2024 Q4 Quarterly Activities Report & Appendix 4CJan 30, 2025Quarterly reportASX
2024 Q3 Quarterly Activities Report and Appendix 4COct 29, 2024Quarterly reportASX
Investor Presentation - 1H FY24 ResultsAug 29, 2024Other filingsASX
IMEXHS Reports 1H FY24 ResultsAug 29, 2024Other filingsASX
2024 Q2 Quarterly Activities Report and Appendix 4CJul 29, 2024Quarterly reportASX
2024 Q1 Quarterly Activities Report and Appendix 4CApr 30, 2024Quarterly reportASX
IMEXHS renews software contractsMar 21, 2024Operations updateASX
IME Successfully Raises $1.5m via a PlacementMar 10, 2024FinancingASX
Trading HaltMar 6, 2024Trading halt or suspensionASX
FY23 Investor PresentationFeb 28, 2024Other filingsASX
IMEXHS Reports FY23 ResultsFeb 28, 2024ResultsASX
Appendix 4EFeb 28, 2024ResultsASX
IMEXHS Q4 FY23 Results PresentationJan 30, 2024Other filingsASX
2023 Q4 Quarterly Activities Report & Appendix 4CJan 29, 2024Quarterly reportASX
2023 Q3 Quarterly Activities Report & Appendix 4COct 29, 2023Quarterly reportASX
IMEXHS signs new 3-year radiology services contractOct 16, 2023Other filingsASX
IMEXHS signs new contract with Colombia's National PoliceOct 10, 2023Other filingsASX
Investor Presentation - 1H FY23 ResultsAug 31, 2023Other filingsASX
IMEXHS Reports 1H FY23 ResultsAug 31, 2023Other filingsASX
IMEXHS wins new 5-year SaaS ContractAug 15, 2023Other filingsASX
2023 Q2 Quarterly Activities Report and Appendix 4CJul 27, 2023Quarterly reportASX
AGM - Chairman & CEO Addresses / PresentationMay 16, 2023Other filingsASX
2023 Q1 Quarterly Activities Report and Appendix 4CApr 28, 2023Quarterly reportASX
IMEXHS wins new contract with Grupo AvidantiApr 16, 2023Other filingsASX
IMEXHS Investor UpdateMar 22, 2023Other filingsASX
IMEXHS wins new radiology services contractMar 5, 2023Other filingsASX
FY22 Investor PresentationFeb 27, 2023Other filingsASX
IMEXHS Reports FY22 ResultsFeb 27, 2023Other filingsASX
2022 Q4 Quarterly Activities Report and Appendix 4CJan 30, 2023Quarterly reportASX
IMEXHS wins new contract with IMSSDec 27, 2022Other filingsASX
2022 Q3 Quarterly Activities Report and Appendix 4COct 30, 2022Quarterly reportASX
EGM - Chairman and CEO AddressesSep 26, 2022Other filingsASX
Investor Presentation - 1H FY22 ResultsAug 29, 2022Other filingsASX
IMEXHS Reports 1H FY22 ResultsAug 29, 2022Other filingsASX
Non-renounceable Entitlement Offer BookletAug 11, 2022FinancingASX
1H FY22 Preliminary Results and Capital RaisingAug 3, 2022FinancingASX
Investor Presentation - Capital RaisingAug 3, 2022FinancingASX
2022 Q2 Quarterly Activities Report and Appendix 4CJul 29, 2022Quarterly reportASX
IMEXHS wins new contract with Colombias National PoliceJul 13, 2022Other filingsASX
IMEXHS renews three-year contract with ColsubsidioJul 12, 2022Other filingsASX
AGM PresentationMay 18, 2022Other filingsASX
FY22 Outlook UpdateApr 29, 2022GuidanceASX
2022 Q1 Quarterly Activities Report and Appendix 4CApr 29, 2022Quarterly reportASX
IMEXHS Strategy PresentationMar 20, 2022Other filingsASX
FY21 Investor PresentationFeb 28, 2022Other filingsASX
IMEXHS Reports FY21 Financial ResultsFeb 28, 2022ResultsASX
2021 Q4 Quarterly Activities Report and Appendix 4CJan 30, 2022Quarterly reportASX
IMEXHS launches Aquila in the Thai MarketJan 20, 2022Other filingsASX
Trading UpdateDec 20, 2021Other filingsASX
2021 Q3 Activity Report and Appendix 4COct 28, 2021Quarterly reportASX
Investor Presentation - 1H FY21 ResultsAug 30, 2021Other filingsASX
IMEXHS reports 1H FY21 Financial ResultsAug 30, 2021ResultsASX
2021 Q2 Activity Report and Appendix 4CJul 30, 2021Quarterly reportASX
Investor Presentation - RIMAB SASJul 25, 2021Other filingsASX
Acquisition of radiology service provider RIMAB SASJul 25, 2021Acquisition or disposalASX
2021 Q1 Activity Report and Appendix 4CApr 29, 2021Quarterly reportASX
Investor Presentation - FY20 ResultFeb 25, 2021Other filingsASX
Appendix 4E - Preliminary Final ReportFeb 25, 2021ResultsASX
2020 Q4 Activity Report and Appendix 4CJan 28, 2021Quarterly reportASX
Strong finish to 2020 for new Aquila in the Cloud productJan 5, 2021Other filingsASX
IMEXHS Successfully Completes $8.3m Capital RaisingOct 21, 2020FinancingASX
Q3 Quarterly Activity Report & Appendix 4COct 18, 2020Quarterly reportASX
Appendix 4D & Half-Year ReportAug 30, 2020Interim reportASX
Q2 Quarterly Activity Report & Appendix 4CJul 29, 2020Quarterly reportASX
Q1 Quarterly Activity Report & Appendix 4CApr 26, 2020Quarterly reportASX
Coronavirus Pandemic UpdateMar 29, 2020Other filingsASX
Quarterly Cashflow and Summary of ActivitiesJan 30, 2020Quarterly reportASX
IMEXHS announces first European SaaS contractDec 2, 2019Other filingsASX
IMEXHS announces new contract with AI-RADNov 26, 2019Other filingsASX
Share Placement to Raise A$10 MillionOct 23, 2019FinancingASX
Quarterly Cash Flow and Summary of ActivitiesOct 18, 2019Quarterly reportASX
IMEXHS announces first Australian customerOct 10, 2019Other filingsASX
Appendix 4D & Half-Year Financial StatementsAug 27, 2019Interim reportASX
IME receives FDA Clearance for Hiruko Essential in the USAAug 5, 2019Other filingsASX
IMEXHS signs US$500,000 term loanJul 31, 2019Other filingsASX
IME signs large Diagnostic Services Contract for ColsubsidioJul 29, 2019Other filingsASX
ImExHS Signs a Distribution Agreement in the US marketJul 15, 2019Other filingsASX
ImExHS signs A$2 million Loan AgreementJul 12, 2019Other filingsASX
ImExHS signs new Saas contract in Puerto RicoJul 3, 2019Other filingsASX
ImExHS extends contract with Clinica Las AmericasMay 28, 2019Other filingsASX
ImExHS Enters into Binding Terms Sheet for New Debt FacilityApr 30, 2019Other filingsASX
Appendix 4E & Preliminary Final ReportFeb 28, 2019ResultsASX
Quarterly Cash Flow and Summary of ActivititesJan 31, 2019Quarterly reportASX
ImExHS signs new distribution agreement in PanamaJan 23, 2019Other filingsASX
Important PaaS deal signed with Colombian radiology companyDec 2, 2018Other filingsASX
IMEXHS signs largest contract to dateOct 21, 2018Other filingsASX
Clinica Palermo contract renewal and upliftOct 14, 2018Other filingsASX
IME extends PaaS contract with large LATAM healthcare groupOct 2, 2018Other filingsASX
Corporate Update & Investor PresentationSep 10, 2018Other filingsASX
Market Announcement - Reinstatement to official quotationSep 4, 2018Trading halt or suspensionASX
Suspension RemainsSep 3, 2018Trading halt or suspensionASX
Supplementary ProspectusAug 10, 2018Offer documentASX
Suspension from Official QuotationJul 30, 2018Trading halt or suspensionASX
Appendix 4C - quarterlyJul 27, 2018Quarterly reportASX
ProspectusJul 23, 2018Offer documentASX
Increase in Capital Raising AmountJun 19, 2018FinancingASX
Corporate PresentationMay 16, 2018Other filingsASX
R&D Cash Refund ReceivedMar 4, 2018Other filingsASX
Full Year Statutory AccountsFeb 28, 2018Annual reportASX
Appendix 4C - quarterly and commentaryOct 22, 2017Quarterly reportASX
Acquisition of RightCrowd and Capital RaiseOct 18, 2016Acquisition or disposalASX
OMT Delivers its First Employee Engagement AppOct 9, 2016Other filingsASX
OMT Completes Convertible Notes Raising and Appendix 3BOct 4, 2016FinancingASX
New Product ReleaseSep 28, 2016Other filingsASX
OMT Appoints New CEOJul 5, 2016Management or board changeASX
OMT Engaged by WestpacMar 30, 2016Other filingsASX
OMT Engaged by Two More ASX-Listed CompaniesFeb 11, 2016Other filingsASX
OMT Partners with Boardroom MediaFeb 10, 2016Other filingsASX

Open Filings

Cap table

Built by 6ix from ImExHS Ltd’s releases

Common shares
54,395,712
Fully diluted
54,395,712

Fully diluted

LineShares
Common shares54,395,712

Share count over time

CountShares
Nov 22, 202654,395,712

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Carlos PalacioNon-Executive Director · Since at least Nov 5, 2026
Damian BanksNon-Executive Director · Since at least Nov 5, 2026
Doug FlynnNon-Executive Chairman · Since at least Nov 5, 2026
Doug LingardNon-Executive Director · Since at least Nov 5, 2026
Germán ArangoCEO & Co-Founder · Since at least Aug 28, 2026
Jorge MarínChief Medical Officer & Co-Founder · Since at least Nov 5, 2026
Orlando JóvenChief Operations Officer · Since at least Nov 5, 2026
Reena MinhasChief Financial Officer · Since at least Jul 28, 2026

Open People

Log in to ask 6ix AI your own questions about ImExHS Ltd.